Skip to main content
SpringerLink
Log in

Digital Glissonectomy: A Safe Perihepatic Peritonectomy

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Complete cytoreductive surgery (CRS), combining organ resection and peritonectomy, is the only treatment that could offer cure for patients with peritoneal carcinomatosis. Initially, when the Glisson’s capsule was involved without deep liver parenchyma invasion, either electroevaporation or Glisson’s capsule resection was proposed. The objective of this study is to present and evaluate the safety of this standardized digital glissonectomy.

Methods

Since 2009, the peritonectomy of the Glisson’s capsule, or digital glissonectomy, has been standardized at our institution.

Results

Among 655 patients who underwent a complete CRS between 2009 and 2014, 91 (14 %) glissonectomies were performed. Pseudomyxoma peritonei was the primary indication, and a glissonectomy was more frequently performed for patients with high peritoneal cancer index. The morbidity and mortality of CRS were not increased after glissonectomy (p = 0.069 and 0.949, respectively).

Conclusions

Digital glissonectomy is feasible and safe, when proposed for superficial deposits on Glisson’s capsule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gilly FN, Sayag AC, Carry PY, Braillon GG, James IM, Volloch AA, Panteix GG. Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report. Int Surg. 1991;76:164–7.

    CAS  PubMed  Google Scholar 

  2. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol. 1989;16:83–97.

    CAS  PubMed  Google Scholar 

  3. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–56.

    Article  PubMed  Google Scholar 

  5. Goere D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065–71.

    Article  PubMed  Google Scholar 

  6. Omohwo C, Nieroda CA, Studeman KD, et al. Complete cytoreduction offers long-term survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009;209:308–12.

    Article  PubMed  Google Scholar 

  7. Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237–42.

    Article  PubMed  Google Scholar 

  8. Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116:5608–18.

    Article  PubMed  Google Scholar 

  9. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.

    Article  CAS  PubMed  Google Scholar 

  10. Passot G, Vaudoyer D, Villeneuve L, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol. 2016;113:796–803.

    Article  PubMed  Google Scholar 

  11. Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, Piso P. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2011;18:1052–9.

    Article  PubMed  Google Scholar 

  12. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mise Y, Vauthey JN, Zimmitti G, et al. Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality. Ann Surg. 2015;262:1071–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Hospices Civils de Lyon, CH Lyon Sud, Lyon, France

    Guillaume Passot MD, PhD, Delphine Vaudoyer MD, Vahan Kepenekian MD, Isabelle Bonnefoy MSc, Naoual Bakrin MD, PhD, Eddy Cotte MD, PhD & Olivier Glehen MD, PhD

  2. EMR 37 38, Lyon 1 University, Oullins, Lyon, France

    Guillaume Passot MD, PhD, Delphine Vaudoyer MD, Vahan Kepenekian MD, Naoual Bakrin MD, PhD, Eddy Cotte MD, PhD & Olivier Glehen MD, PhD

  3. Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA

    Bradford J. Kim MD, MHS

Authors
  1. Guillaume Passot MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradford J. Kim MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Delphine Vaudoyer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vahan Kepenekian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Isabelle Bonnefoy MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naoual Bakrin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eddy Cotte MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Olivier Glehen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guillaume Passot MD, PhD.

Ethics declarations

Conflicts of Interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Passot, G., Kim, B.J., Vaudoyer, D. et al. Digital Glissonectomy: A Safe Perihepatic Peritonectomy. Ann Surg Oncol 23, 3978–3985 (2016). https://doi.org/10.1245/s10434-016-5342-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5342-9

Keywords

Search

Navigation